HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

J J Body Selected Research

ibandronic acid (Boniva)

11/2011How to manage postmenopausal osteoporosis?
11/2008Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review.
7/2006Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results.
12/2005Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy.
8/2005Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
3/2004Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies.
7/2002Bisphosphonates for cancer patients: why, how, and when?
11/2000Bisphosphonates induce breast cancer cell death in vitro.
6/2000Current and future directions in medical therapy: hypercalcemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


J J Body Research Topics

Disease

18Breast Neoplasms (Breast Cancer)
04/2013 - 09/2000
11Neoplasms (Cancer)
09/2014 - 06/2000
10Pain (Aches)
09/2014 - 07/2000
10Neoplasm Metastasis (Metastasis)
09/2014 - 09/2000
10Bone Diseases (Bone Disease)
11/2008 - 06/2000
10Bone Resorption
09/2008 - 06/2000
7Hypercalcemia (Milk Alkali Syndrome)
05/2013 - 06/2000
5Osteoporosis
09/2012 - 09/2000
3Postmenopausal Osteoporosis
11/2008 - 09/2007
2Prostatic Neoplasms (Prostate Cancer)
04/2013 - 11/2008
2Hip Fractures (Intertrochanteric Fractures)
11/2011 - 09/2008
2Renal Insufficiency (Renal Failure)
11/2008 - 10/2001
1Drug Toxicity (Drug Safety)
12/2014
1Primary Hyperparathyroidism
12/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013
1Premature Menopause
10/2012
1Stroke (Strokes)
11/2011
1Venous Thromboembolism
11/2011
1Hyperparathyroidism
09/2008
1Metabolic Bone Diseases (Osteopenia)
03/2008
1Osteitis Deformans (Paget's Disease of Bone)
11/2005
1Hypocalcemia
11/2005
1Congenital Abnormalities (Deformity)
11/2005
1Neuralgia (Stump Neuralgia)
10/2004
1Diabetic Neuropathies (Diabetic Neuropathy)
10/2004
1Spontaneous Fractures (Pathological Fracture)
10/2001
1Melanoma (Melanoma, Malignant)
10/2001
1Multiple Myeloma
10/2001
1Esophagitis
08/2001
1Necrosis
11/2000
1Osteolysis
11/2000
1Confusion (Bewilderment)
07/2000
1Nausea
07/2000
1Myoclonus (Nocturnal Myoclonus)
07/2000
1Delirium
07/2000
1Vomiting
07/2000
1Inappropriate ADH Syndrome (SIADH)
05/2000
1Hemorrhage
02/2000

Drug/Important Bio-Agent (IBA)

16DiphosphonatesIBA
09/2014 - 06/2000
9ibandronic acid (Boniva)FDA Link
11/2011 - 06/2000
8zoledronic acid (zoledronate)FDA Link
04/2013 - 11/2000
6CalciumIBA
09/2008 - 06/2000
6pamidronate (APD)FDA LinkGeneric
12/2005 - 06/2000
4HormonesIBA
09/2014 - 05/2000
4Clodronic Acid (Clodronate)IBA
03/2008 - 11/2000
3Raloxifene (Evista)FDA Link
11/2011 - 02/2000
3Biological Markers (Surrogate Marker)IBA
11/2007 - 07/2002
2cinacalcet (Sensipar)FDA Link
12/2014 - 09/2012
2Estrogens (Estrogen)FDA Link
10/2012 - 09/2000
2Teriparatide (Parathar)FDA Link
09/2008 - 09/2002
2Vitamin DFDA LinkGeneric
09/2008 - 11/2005
2Opioid Analgesics (Opioids)IBA
10/2004 - 07/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2002 - 10/2001
2CytokinesIBA
07/2002 - 10/2001
2Hydroxyproline (4 Hydroxyproline)IBA
10/2001 - 09/2000
2Parathyroid Hormone-Related ProteinIBA
10/2001 - 09/2000
1denosumabFDA Link
09/2014
1collagen type I trimeric cross-linked peptideIBA
04/2013
1Collagen Type I (Type I Collagen)IBA
04/2013
1Aromatase InhibitorsIBA
11/2012
1CreatinineIBA
09/2012
1Aromatase (CYP19)IBA
12/2011
1Carbon MonoxideIBA
11/2008
1Selective Estrogen Receptor Modulators (SERM)IBA
09/2008
1Parathyroid Hormone (Parathormone)IBA
09/2008
1strontium ranelate (protelos)IBA
09/2008
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2007
1TamoxifenFDA LinkGeneric
11/2007
1Alkaline PhosphataseIBA
11/2005
1NitrogenIBA
08/2005
1Carbamazepine (Tegretol)FDA LinkGeneric
10/2004
1gabapentin (Neurontin)FDA LinkGeneric
10/2004
1Anticonvulsants (Antiepileptic Drugs)IBA
10/2004
1Antineoplastic Agents (Antineoplastics)IBA
07/2002
1OsteocalcinIBA
10/2001
1Transforming Growth Factor beta (TGF-beta)IBA
10/2001
1Conditioned Culture MediaIBA
09/2001
1Messenger RNA (mRNA)IBA
08/2001
1Interleukin-11 (Interleukin 11)IBA
08/2001
1Interleukin-6 (Interleukin 6)IBA
08/2001
1Morphine (MS Contin)FDA LinkGeneric
04/2001
1Methadone (Dolophine)FDA LinkGeneric
07/2000
1SodiumIBA
05/2000

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2012 - 07/2002
2Subcutaneous Injections
11/2011 - 09/2002
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
11/2011 - 09/2002
2Oral Administration
03/2008 - 08/2001
1Fluid Therapy (Oral Rehydration Therapy)
05/2013
1Castration
04/2013
1Injections
11/2008
1Radiotherapy
10/2001